APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study
about
Association of SNP3 polymorphism in the apolipoprotein A-V gene with plasma triglyceride level in Tunisian type 2 diabetesAPOAV (T-1131>C) variant has no effect on mother's height in a large population studyEffects of APOA5 -1131T>C (rs662799) on fasting plasma lipids and risk of metabolic syndrome: evidence from a case-control study in China and a meta-analysisIs apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network studyGenetic variants associated with VLDL, LDL and HDL particle size differ with race/ethnicityIncreased concentrations of circulating vitamin E in carriers of the apolipoprotein A5 gene - 1131T>C variant and associations with plasma lipids and lipid peroxidation.Association of the apolipoprotein A5 gene -1131 T>C polymorphism with fasting blood lipids: a meta-analysis in 37859 subjects.Interactions of the apolipoprotein A5 gene polymorphisms and alcohol consumption on serum lipid levels.Genomic determinants of triglyceride and cholesterol distribution into lipoprotein fractions in the ratGenetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction.Influences of APOA5 variants on plasma triglyceride levels in Uyghur populationInfluence of genetic variants in the apolipoprotein A5 and C3 gene on lipids, lipoproteins, and its association with coronary artery disease in Indians.Haplotype analysis of the Apolipoprotein A5 gene in Moroccan patients with the metabolic syndromeGenetic association and interaction analysis of USF1 and APOA5 on lipid levels and atherosclerosisAssociation of apolipoprotein A5 concentration with serum insulin and triglyceride levels and coronary artery disease in Korean men.The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery diseaseCerebrovascular atherosclerosis in type III hyperlipidemia is modulated by variation in the apolipoprotein A5 geneMolecular genetics of myocardial infarctionGene transfer of apolipoprotein A-V improves the hypertriglyceridemic phenotype of apoa5 (-/-) mice.Apolipoprotein polymorphisms and familial hypercholesterolemia.Nutrigenetics and personalised nutrition: how far have we progressed and are we likely to get there?Association of APOA5 rs662799 and rs3135506 polymorphisms with arterial hypertension in Moroccan patients.Consumption of whole grains and legumes modulates the genetic effect of the APOA5 -1131C variant on changes in triglyceride and apolipoprotein A-V concentrations in patients with impaired fasting glucose or newly diagnosed type 2 diabetes.Different effects of apolipoprotein A5 SNPs and haplotypes on triglyceride concentration in three ethnic origins.Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome.Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study.The ins (cell) and outs (plasma) of apolipoprotein A-V.Apolipoprotein A-V: a potential modulator of plasma triglyceride levels in Turks.Administration of a PPARalpha agonist increases serum apolipoprotein A-V levels and the apolipoprotein A-V/apolipoprotein C-III ratio.Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults.APO A-V-1131T-->C polymorphism frequency and its association with morbidity in a Brazilian elderly population.A promoter variant of the APOA5 gene increases atherogenic LDL levels and arterial stiffness in hypertriglyceridemic patients.Effects of ID-alG™ on weight management and body fat mass in high-fat-fed rats.Influence of apoA-V gene variants on postprandial triglyceride metabolism: impact of gender.APOA5 variants and metabolic syndrome in Caucasians.Comparison of low-fat meal and high-fat meal on postprandial lipemic response in non-obese men according to the -1131T>C polymorphism of the apolipoprotein A5 (APOA5) gene (randomized cross-over design).Variants at the APOA5 locus, association with carotid atherosclerosis, and modification by obesity: the Framingham Study.Influence of APOA5 Locus on the Treatment Efficacy of Three Statins: Evidence From a Randomized Pilot Study in Chinese Subjects.Effects of polymorphisms in APOA5 on the plasma levels of triglycerides and risk of coronary heart disease in Jilin, northeast China: a case-control study.
P2860
Q24791712-0228A28B-904A-43F8-BF83-9CFCABBAD061Q24794937-8A46F078-6BC3-47FF-8785-52F7EEAB00A5Q28286797-EC757766-E589-49E3-999D-9870D6CEDBE2Q28294769-D82011EB-AE57-4037-A511-785EE379C23AQ28302934-6209544F-CACD-4EEF-B3A7-14352C1D6CEBQ30414022-FA491B47-A909-4286-B82C-2881C6176CD9Q33293923-DF0103E8-6B3C-4132-A361-5C48A442DD74Q33653008-C5829BBD-AEA8-4B35-BC31-1EF40B20CCABQ33851689-2DE3E8AB-3E37-4DBF-BC7B-0B035D20A26CQ34308879-1341941B-978A-4FF3-89F6-9F01805A03B3Q34318279-8059E280-FC9D-4E42-ABE3-C8828C3E244EQ34338496-8AE290BB-81F5-40CB-9412-BF96FA4F019FQ35263542-7EB5DD0B-4A9C-49FA-8492-BC72F5DB98D8Q35532345-91EBA5FC-B8A7-443C-B41C-1BCFF7F9D9BAQ35575550-2693A910-9B7E-49A6-988B-0DBE3B568632Q35591965-3077DC35-36AA-4AB4-BEBE-2AAE69135DE8Q35596411-6D18C01E-3D8E-4DE3-910D-15E547ED5A49Q35963956-85E0DF12-912E-4E00-816F-999018B7C7FDQ36843011-809B1F09-450E-4A3B-B456-89CF0A3BBC0BQ36856055-1CEA714F-0133-456A-BFF1-AAEF435CF029Q36966031-5090CD7F-AA3A-4BDA-B5D8-A35CFD174699Q37401949-A847B141-B92B-4C84-8D30-1FA6F5737E25Q37679793-F9A2AAB3-D05A-44B7-B373-F12311C9733BQ37682045-5699862B-F2E0-44AC-8979-E54EA2787464Q39127971-194B2052-14B0-456B-87F9-13C8AD1EC637Q39805075-211EF461-5A61-4D58-B433-D0D84805EF4BQ40316899-9E0666A8-A7FD-4D49-9D5D-2CD4F693A7DFQ42119866-35F24A58-22CF-4A37-A145-FB58B3E47052Q46147591-602E920E-1677-42B9-BDE4-9D31EA4936BFQ46493763-DF4B53E5-1393-4552-A59E-947D45307428Q46501910-BF8AAD78-03EA-4586-990B-0E5D97921D6BQ46866298-95F72971-E39B-4897-AA5C-DC6CF46F361CQ47164479-7E642C35-5A5C-4B63-8CAF-006DAB257044Q47347141-BB2D8DC1-7EE7-4C5A-BF77-7A390F9074D9Q51454108-79D79DB5-64D5-4573-A4C8-104CF6EE5522Q51464229-E7F3C59A-940C-4FEC-9411-44E54D5F13FDQ51490891-4EE51E16-C0C6-4910-A3CC-6CDEBA498AD3Q51503282-2E1627B2-7C90-4C9D-8773-A12012F39948Q55017020-FBA303A4-E76B-4AA5-843B-7BD8A04887B3Q55119107-F7C61A0A-92A6-41DA-8C15-686B3F19488C
P2860
APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
APOA5 gene variants, lipoprote ...... : results from the LOCAT study
@ast
APOA5 gene variants, lipoprote ...... : results from the LOCAT study
@en
APOA5 gene variants, lipoprote ...... : results from the LOCAT study
@en-gb
APOA5 gene variants, lipoprote ...... : results from the LOCAT study
@nl
type
label
APOA5 gene variants, lipoprote ...... : results from the LOCAT study
@ast
APOA5 gene variants, lipoprote ...... : results from the LOCAT study
@en
APOA5 gene variants, lipoprote ...... : results from the LOCAT study
@en-gb
APOA5 gene variants, lipoprote ...... : results from the LOCAT study
@nl
prefLabel
APOA5 gene variants, lipoprote ...... : results from the LOCAT study
@ast
APOA5 gene variants, lipoprote ...... : results from the LOCAT study
@en
APOA5 gene variants, lipoprote ...... : results from the LOCAT study
@en-gb
APOA5 gene variants, lipoprote ...... : results from the LOCAT study
@nl
P2093
P2860
P921
P1476
APOA5 gene variants, lipoprote ...... : results from the LOCAT study
@en
P2093
Amos Pasternack
M Heikki Frick
Markku S Nieminen
Mikko Syvänne
Steve E Humphries
Steve Martin
Y Antero Kesäniemi
P2860
P356
10.1194/JLR.M300458-JLR200
P407
P577
2004-04-01T00:00:00Z